Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York

Tamar A. Smith-Norowitz; Jonathan I. Silverberg; Esther M. Norowitz; Stephan Kohlhoff; Margaret R. Hammerschlag

doi:10.1080/21645515.2021.1948786

Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York

Tamar A. Smith-Norowitz
, Jonathan I. Silverberg
, Esther M. Norowitz
, Stephan Kohlhoff
, Margaret R. Hammerschlag

Pediatrics

SUNY Downstate Health Sciences University

SUNY Downstate Health Sciences University
George Washington University

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

The Coronavirus disease-2019 (COVID-19) pandemic led to the development of several candidate vaccines. However, current research suggests that the potential of successful vaccines is tempered by vaccine skepticism or hesitancy. If vaccine efficacy is 80%, then the herd immunity required from vaccination is about 75-90%. The aim of the current study was to study factors impacting COVID-19 vaccine hesitancy in a representative sample of adults (age≥18 years) in a COVID-19 hotspot Abbreviations: COVID-19: coronavirus disease-19.

Original language	English
Pages (from-to)	4013-4014
Number of pages	2
Journal	Human Vaccines and Immunotherapeutics
Volume	17
Issue number	11
DOIs	https://doi.org/10.1080/21645515.2021.1948786
State	Published - 2021

Keywords

COVID-19
COVID-19 vaccine
New York
seasonal influenza vaccine
vaccine hesitancy

Access to Document

10.1080/21645515.2021.1948786

Cite this

@article{0a83e92a6e3a402cbf84204193735e85,

title = "Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York",

abstract = "The Coronavirus disease-2019 (COVID-19) pandemic led to the development of several candidate vaccines. However, current research suggests that the potential of successful vaccines is tempered by vaccine skepticism or hesitancy. If vaccine efficacy is 80\%, then the herd immunity required from vaccination is about 75-90\%. The aim of the current study was to study factors impacting COVID-19 vaccine hesitancy in a representative sample of adults (age≥18 years) in a COVID-19 hotspot Abbreviations: COVID-19: coronavirus disease-19.",

keywords = "COVID-19, COVID-19 vaccine, New York, seasonal influenza vaccine, vaccine hesitancy",

author = "Smith-Norowitz, \{Tamar A.\} and Silverberg, \{Jonathan I.\} and Norowitz, \{Esther M.\} and Stephan Kohlhoff and Hammerschlag, \{Margaret R.\}",

note = "Publisher Copyright: {\textcopyright} 2021 Taylor \& Francis Group, LLC.",

year = "2021",

doi = "10.1080/21645515.2021.1948786",

language = "English",

volume = "17",

pages = "4013--4014",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

publisher = "Taylor and Francis Ltd.",

number = "11",

}

TY - JOUR

T1 - Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York

AU - Smith-Norowitz, Tamar A.

AU - Silverberg, Jonathan I.

AU - Norowitz, Esther M.

AU - Kohlhoff, Stephan

AU - Hammerschlag, Margaret R.

PY - 2021

Y1 - 2021

N2 - The Coronavirus disease-2019 (COVID-19) pandemic led to the development of several candidate vaccines. However, current research suggests that the potential of successful vaccines is tempered by vaccine skepticism or hesitancy. If vaccine efficacy is 80%, then the herd immunity required from vaccination is about 75-90%. The aim of the current study was to study factors impacting COVID-19 vaccine hesitancy in a representative sample of adults (age≥18 years) in a COVID-19 hotspot Abbreviations: COVID-19: coronavirus disease-19.

AB - The Coronavirus disease-2019 (COVID-19) pandemic led to the development of several candidate vaccines. However, current research suggests that the potential of successful vaccines is tempered by vaccine skepticism or hesitancy. If vaccine efficacy is 80%, then the herd immunity required from vaccination is about 75-90%. The aim of the current study was to study factors impacting COVID-19 vaccine hesitancy in a representative sample of adults (age≥18 years) in a COVID-19 hotspot Abbreviations: COVID-19: coronavirus disease-19.

KW - COVID-19

KW - COVID-19 vaccine

KW - New York

KW - seasonal influenza vaccine

KW - vaccine hesitancy

UR - https://www.scopus.com/pages/publications/85110301827

U2 - 10.1080/21645515.2021.1948786

DO - 10.1080/21645515.2021.1948786

M3 - Article

C2 - 34242124

SN - 2164-5515

VL - 17

SP - 4013

EP - 4014

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

IS - 11

ER -

Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this